Log in to save to my catalogue

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3154015e3e6146dd96234b07e9394342

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

About this item

Full title

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2023-12, Vol.14 (12), p.790-790, Article 790

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Aurora-A kinase interacting protein 1 (AURKAIP1) has been proved to take an intermediary role in cancer by functioning as a negative regulator of Aurora-A kinase. However, it remains unclear whether and how AURKAIP1 itself would directly engage in regulating malignancies. The expression levels of AURKAIP1 were detected in triple negative breast can...

Alternative Titles

Full title

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3154015e3e6146dd96234b07e9394342

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3154015e3e6146dd96234b07e9394342

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-023-06115-1

How to access this item